Naunyn-Schmiedeberg's Arch Pharmacol 399 , 1261312627 (2026)
The American Journal of Clinical Nutrition , 69 (6), 11351143
Yoon HS, Cho CH, Yun MS, Jang SJ, You HJ, Kim JH, et al
and Olek, R.A
doi:10.3390/jcm12010145 Gebrayel P, Nicco C, Al Khodor S, Bilinski J, Caselli E, Comelli EM, Egert M, Giaroni C, Karpinski TM, Loniewski I, Mulak A, Reygner J, Samczuk P, Serino M, Sikora M, Terranegra A, Ufnal M, Villeger R, Pichon C, Konturek P, Edeas M
Together, these modifications produce a compound with substantially lower systemic plasma clearance than GHRP-6 approximately five-fold lower and moderate resistance to metabolic degradation, resulting in a more sustained and reproducible GH secretory response